Maria Maddalena Cavalluzzi

Prof. Maria Maddalena Cavalluzzi

University of Bari Aldo Moro, Bari, Puglia, Italy
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2016 in Molecules
Verified
Journal Article
Open access
PDF file
RGRoberta Gualdani
Roberta Gualdani
Maria Maddalena CavalluzziMaria Maddalena Cavalluzzi
Maria Maddalena Cavalluzzi
Giovanni LentiniGiovanni Lentini
Giovanni Lentini
Solomon HabtemariamSolomon Habtemariam
Solomon Habtemariam
Citrus limonoids (CLs) are a group of highly oxygenated terpenoid secondary metabolites found mostly in the seeds, fruits and peel tissues of citrus fruits such as lemons, limes, oranges, pumellos, grapefruits, bergamots, and mandarins. Represented by limonin, the aglycones and glycosides of CLs have shown to display numerous pharmacological activities including anticancer, antimicrobial, antioxidant, antidiabetic and insecticidal among others. In this review, the chemistry and pharmacology of CLs are systematically scrutinised through the use of medicinal chemistry tools and structure-activity relationship approach. Synthetic derivatives and other structurally-related limonoids from other sources are include in the analysis. With the focus on literature in the past decade, the chemical classification of CLs, their physico-chemical properties as drugs, their biosynthesis and enzymatic modifications, possible ways of enhancing their biological activities through structural modifications, their ligand efficiency metrics and systematic graphical radar plot analysis to assess their developability as drugs are among those discussed in detail.

29 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
VTVincenzo Tragni
Vincenzo Tragni
GPGuido Primiano
Guido Primiano
ATAlbina Tummolo
Albina Tummolo
LBLucas Cafferati Beltrame
Lucas Cafferati Beltrame
GPGianluigi La Piana
Gianluigi La Piana
Ciro Leonardo PierriCiro Leonardo Pierri
Ciro Leonardo Pierri
Mitochondrial diseases (MDs) may result from mutations affecting nuclear or mitochondrial genes, encoding mitochondrial proteins, or non-protein-coding mitochondrial RNA. Despite the great variability of affected genes, in the most severe cases, a neuromuscular and neurodegenerative phenotype is observed, and no specific therapy exists for a complete recovery from the disease. The most used treatments are symptomatic and based on the administration of antioxidant cocktails combined with antiepileptic/antipsychotic drugs and supportive therapy for multiorgan involvement. Nevertheless, the real utility of antioxidant cocktail treatments for patients affected by MDs still needs to be scientifically demonstrated. Unfortunately, clinical trials for antioxidant therapies using α-tocopherol, ascorbate, glutathione, riboflavin, niacin, acetyl-carnitine and coenzyme Q have met a limited success. Indeed, it would be expected that the employed antioxidants can only be effective if they are able to target the specific mechanism, i.e., involving the central and peripheral nervous system, responsible for the clinical manifestations of the disease. Noteworthily, very often the phenotypes characterizing MD patients are associated with mutations in proteins whose function does not depend on specific cofactors. Conversely, the administration of the antioxidant cocktails might determine the suppression of endogenous oxidants resulting in deleterious effects on cell viability and/or toxicity for patients. In order to avoid toxicity effects and before administering the antioxidant therapy, it might be useful to ascertain the blood serum levels of antioxidants and cofactors to be administered in MD patients. It would be also worthwhile to check the localization of mutations affecting proteins whose function should depend (less or more directly) on the cofactors to be administered, for estimating the real need and predicting the success of the proposed cofactor/antioxidant-based therapy.

31 October 2003 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CFCarlo FRANCHINI
Carlo FRANCHINI
ACAlessia Carocci
Alessia Carocci
ACAlessia Catalano
Alessia Catalano
Maria Maddalena CavalluzziMaria Maddalena Cavalluzzi
Maria Maddalena Cavalluzzi
Filomena CorboFilomena Corbo
Filomena Corbo
ALAnnamaria De Luca
Annamaria De Luca

5 January 2020 in Molecules
Verified
Journal Article
Open access
PDF file
GMGualtiero Milani
Gualtiero Milani
FCFrancesca Curci
Francesca Curci
Maria Maddalena CavalluzziMaria Maddalena Cavalluzzi
Maria Maddalena Cavalluzzi
Pasquale CrupiPasquale Crupi
Pasquale Crupi
IPISABELLA PISANO
ISABELLA PISANO
Filomena CorboFilomena Corbo
Filomena Corbo
Bamboo is a well-known medicinal plant in Southeast Asia that recently has attracted attention for its high polyphenol content and its medical and nutraceutical applications. In this work, polyphenols have been recovered for the first time by microwave-assisted extraction (MAE) from an unusual Italian cultivar of Phyllostachys pubescens bamboo shoots. The effects of three independent variables, such as extraction time, temperature, and solid/liquid ratio, on polyphenol recovery yield were investigated and successfully optimized through the response surface methodology. We demonstrated that MAE is an excellent polyphenols extraction technique from bamboo shoots because the total phenolic content obtained under microwave irradiation optimal conditions (4 min at 105 °C with 6.25 mg/mL ratio) was about eight-fold higher than that obtained with the conventional extraction method. Furthermore, higher total flavonoid content was also obtained under MAE. Consistent with these results, MAE enhanced the extract antioxidant properties with significant improved DPPH, ABTS, and FRAP scavenging ability. Therefore, this innovative extraction process enhances the recovery of biologically active compounds from Phyllostachys pubescens bamboo shoots with a dramatic reduction of time and energy consumption, which paves the way for its industrial application in functional food production.

17 June 2018 in Biomedicines
Verified
Journal Article
Open access
PDF file
Leonardo CaputoLeonardo Caputo
Leonardo Caputo
LQLaura Quintieri
Laura Quintieri
Maria Maddalena CavalluzziMaria Maddalena Cavalluzzi
Maria Maddalena Cavalluzzi
Giovanni LentiniGiovanni Lentini
Giovanni Lentini
Solomon HabtemariamSolomon Habtemariam
Solomon Habtemariam
Citrus pomace is a huge agro-food industrial waste mostly composed of peels and traditionally used as compost or animal feed. Owing to its high content of compounds beneficial to humans (e.g., flavonoids, phenol-like acids, and terpenoids), citrus waste is increasingly used to produce valuable supplements, fragrance, or antimicrobials. However, such processes require sustainable and efficient extraction strategies by solvent-free techniques for environmentally-friendly good practices. In this work, we evaluated the antimicrobial and antibiofilm activity of water extracts of three citrus peels (orange, lemon, and citron) against ten different sanitary relevant bacteria. Both conventional extraction methods using hot water (HWE) and microwave-assisted extraction (MAE) were used. Even though no extract fully inhibited the growth of the target bacteria, these latter (mostly pseudomonads) showed a significant reduction in biofilm biomass. The most active extracts were obtained from orange and lemon peel by using MAE at 100 °C for 8 min. These results showed that citrus peel water infusions by MAE may reduce biofilm formation possibly enhancing the susceptibility of sanitary-related bacteria to disinfection procedures.

1 August 2010 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
RPRossana Pascale
Rossana Pascale
ACAlessia Carocci
Alessia Carocci
ACAlessia Catalano
Alessia Catalano
Giovanni LentiniGiovanni Lentini
Giovanni Lentini
Anna SpagnolettaAnna Spagnoletta
Anna Spagnoletta
CFCarlo FRANCHINI
Carlo FRANCHINI